“…For example, EGCG act as an inhibitor, which can suppress the hydrolysis of starch by binding to active site of α-amylase and α-glucosidase (Zhang et al, 2018a;Li et al, 2018). EGCG can accelerate the utilization of glucose through attenuating insulin signalling blockade (Lin & Lin, 2008;Bose et al, 2008), protect pancreatic islet cells (Song et al, 2003), and protect some other important organs, like kidney (Yoon et al, 2014;Cai et al, 2013;Periandavan et al, 2017) and liver (El-Mahalaway et al, 2013). EGCG also can reduce the absorptive of glucolipid in intestine tract (Nakai et al, 2005;Li et al, 2018), down-regulate the expression of sodiumdependent glucose cotransporter 1 (Hossain et al, 2002), promote glucose transporter 4 translocation in skeletal muscle (Ueda et al, 2008), attenuate insulin signaling blockade (Lin & Lin, 2008) etc.…”